Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aldose Reductase: a cause and a potential target for the treatment of diabetic complications
Authors
Keywords
-
Journal
ARCHIVES OF PHARMACAL RESEARCH
Volume 44, Issue 7, Pages 655-667
Publisher
Springer Science and Business Media LLC
Online
2021-07-19
DOI
10.1007/s12272-021-01343-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Two Cu( II )‐based coordination polymers: Treatment activity on diabetic nephropathy via reducing aldose reductase activity and blood glucose concentration
- (2021) Li‐Hua Zhou et al. JOURNAL OF THE CHINESE CHEMICAL SOCIETY
- Multifunctional agents based on benzoxazolone as promising therapeutic drugs for diabetic nephropathy
- (2021) Xin Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of selective hybrid coumarin-thiazolidinedione aldose reductase-II inhibitors as potential antidiabetics
- (2021) Vijay Kumar Pasala et al. BIOORGANIC CHEMISTRY
- WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling
- (2020) Xiaoyu Zhou et al. Oxidative Medicine and Cellular Longevity
- Effect of glutathione liposomes on diabetic nephropathy based on oxidative stress and polyol pathway mechanism
- (2020) Huajuan Shen et al. JOURNAL OF LIPOSOME RESEARCH
- Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats
- (2019) Laura G. Sánchez-Lozada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aldose reductase inhibitors: 2013-present
- (2019) Luca Quattrini et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors
- (2019) Yunpeng Ji et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Role of aldose reductase in diabetes-induced retinal microglia activation
- (2019) Kun-Che Chang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Addition of the Aldose Reductase Inhibitor Benzofuroxane Derivative BF-5m to Prolonged and Moderate Exercise Training Enhanced Protection of the Rat Heart From Type-1 Diabetes
- (2019) Bartolo Ferraro et al. Frontiers in Pharmacology
- Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors
- (2019) Manar G. Salem et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Polymorphisms in Sorbitol-Aldose Reductase (Polyol) Pathway Genes and Their Influence on Risk of Diabetic Retinopathy Among Han Chinese
- (2019) Wenliang Li et al. MEDICAL SCIENCE MONITOR
- Relationship between aldose reductase enzyme and the signaling pathway of protein kinase C in the in vitro diabetic retinopathy model
- (2019) Mutlu Sarikaya et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Taxifolin Shows Anticataractogenesis and Attenuates Diabetic Retinopathy In STZ-Diabetic Rats via Suppression of Aldose Reductase, Oxidative Stress and MAPK Signaling Pathway
- (2019) Fei Liu et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Astaxanthin inhibits aldose reductase activity in Psammomys obesus , a model of type 2 diabetes and diabetic retinopathy
- (2019) Maha Benlarbi‐Ben Khedher et al. Food Science & Nutrition
- Triglyceride-lowering effect of the aldose reductase inhibitor cemtirestat—another factor that may contribute to attenuation of symptoms of peripheral neuropathy in STZ-diabetic rats
- (2019) Marta Soltesova Prnova et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The aldose reductase inhibitor epalrestat exerts nephritic protection on diabetic nephropathy in db/db mice through metabolic modulation
- (2018) Jun He et al. ACTA PHARMACOLOGICA SINICA
- Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
- (2018) Jing Xu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets
- (2018) Saikat Dewanjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol
- (2018) Antonella Smeriglio et al. FITOTERAPIA
- Novel aldose reductase inhibitory and antioxidant chlorogenic acid derivatives obtained by heat treatment of chlorogenic acid and amino acids
- (2018) Seung Hwan Hwang et al. FOOD CHEMISTRY
- Sorbinil, an aldolase reductase inhibitor, in fighting against diabetic complications
- (2018) Qi Huang et al. Medicinal Chemistry
- Cellular death, reactive oxygen species (ROS) and diabetic complications
- (2018) Caroline Maria Oliveira Volpe et al. Cell Death & Disease
- Aldose reductase inhibitor ranirestat significantly improves nerve conduction velocity in diabetic polyneuropathy: a randomized double-blind placebo-controlled study in Japan
- (2018) Kenji Sekiguchi et al. Journal of Diabetes Investigation
- New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
- (2017) Eva L. Feldman et al. NEURON
- Strong inhibition of the polyol pathway diverts glucose flux to protein glycation leading to rapid establishment of secondary complications in diabetes mellitus
- (2016) Ashwini D. Jagdale et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Pharmacophore and docking-based hierarchical virtual screening for the designing of aldose reductase inhibitors: synthesis and biological evaluation
- (2016) Bhawna Vyas et al. MEDICINAL CHEMISTRY RESEARCH
- Aldose reductase, ocular diabetic complications and the development of topical Kinostat ®
- (2016) Peter F. Kador et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications
- (2016) Liang-Jun Yan et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Aldose reductase expression as a risk factor for cataract
- (2015) Anson Snow et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic Diseases
- (2015) Ajmer Singh Grewal et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Targeting Aldose Reductase for the Treatment of Diabetes Complications and Inflammatory Diseases: New Insights and Future Directions
- (2014) Rosanna Maccari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Development of aldose reductase inhibitors for the treatment of inflammatory disorders
- (2013) Maria Chatzopoulou et al. Expert Opinion on Drug Discovery
- Additive effect of aldose reductase Z-4 microsatellite polymorphism and glycaemic control on cataract development in type 2 diabetes
- (2013) Ying Wang et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Aldose Reductase Inhibitors of Plant Origin
- (2013) Ciddi Veeresham et al. PHYTOTHERAPY RESEARCH
- Bioflavonoid ellagic acid inhibits aldose reductase: Implications for prevention of diabetic complications
- (2013) Chandrasekhar Akileshwari et al. Journal of Functional Foods
- Effects of Long-Term Treatment with Ranirestat, a Potent Aldose Reductase Inhibitor, on Diabetic Cataract and Neuropathy in Spontaneously Diabetic Torii Rats
- (2013) Ayumi Ota et al. Journal of Diabetes Research
- Understanding the Role of Aldose Reductase in Ocular Inflammation
- (2012) U.C.S. Yadav et al. CURRENT MOLECULAR MEDICINE
- Osmotic stress induced oxidative damage: Possible mechanism of cataract formation in diabetes
- (2012) Zehra Hashim et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia
- (2012) Ni-Huiping Son et al. PLoS One
- Aldose Reductase, Oxidative Stress, and Diabetic Mellitus
- (2012) Wai Ho Tang et al. Frontiers in Pharmacology
- Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE)
- (2011) Shahid P. Baba et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Genetic deficiency of aldose reductase counteracts the development of diabetic nephropathy in C57BL/6 mice
- (2011) H. Liu et al. DIABETOLOGIA
- Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold
- (2011) Xin Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of aldose reductase and anti-cataract action of trans-anethole isolated from Foeniculum vulgare Mill. fruits
- (2011) Vandana Dongare et al. FOOD CHEMISTRY
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- Diabetic cataracts: mechanisms and management
- (2010) Irina G. Obrosova et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Enzymes involved in osmolyte synthesis: How does oxidative stress affect osmoregulation in renal cells?
- (2010) Jesús A. Rosas-Rodríguez et al. LIFE SCIENCES
- Polyol pathway and diabetic nephropathy revisited: Early tubular cell changes and glomerulopathy in diabetic mice overexpressing human aldose reductase
- (2010) Yasuhiro Hashimoto et al. Journal of Diabetes Investigation
- Aldo-Keto Reductases in the Eye
- (2010) Shun Ping Huang et al. Journal of Ophthalmology
- Diabetic Cataract—Pathogenesis, Epidemiology and Treatment
- (2010) Andreas Pollreisz et al. Journal of Ophthalmology
- Aldose reductase: A novel therapeutic target for inflammatory pathologies
- (2009) Kota V. Ramana et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
- (2009) Kate E. Schemmel et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Ranirestat (AS-3201), a Potent Aldose Reductase Inhibitor, Reduces Sorbitol Levels and Improves Motor Nerve Conduction Velocity in Streptozotocin-Diabetic Rats
- (2008) Takafumi Matsumoto et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now